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Abstract
Background: The Mycobacterium tuberculosis 19-kDa lipoprotein has been reported to stimulate
both T and B cell responses as well as induce a number of Th1 cytokines. In order to evaluate the
Mycobacterium avium subsp. paratuberculosis (M. avium subsp. paratuberculosis) 19-kDa lipoprotein as
an immunomodulator in cattle with Johne's disease, the gene encoding the 19-kDa protein
(MAP0261c) was analyzed.
Results: MAP0261c is conserved in mycobacteria, showing a 95% amino acid identity in M. avium
subspecies avium, 84% in M. intracellulare and 76% in M. bovis and M. tuberculosis. MAP0261c was
cloned, expressed, and purified as a fusion protein with the maltose-binding protein (MBP-19 kDa)
in Escherichia coli. IFN-γ production was measured from 21 naturally infected and 9 control cattle
after peripheral blood mononuclear cells (PBMCs) were stimulated with a whole cell lysate (WCL)
of M. avium subsp. paratuberculosis or the recombinant MBP-19 kDa. Overall, the mean response
to MBP-19 kDa was not as strong as the mean response to the WCL. By comparison, cells from
control, non-infected cattle did not produce IFN-γ after stimulation with either WCL or MBP-19
kDa. To assess the humoral immune response to the 19-kDa protein, sera from cattle with clinical
Johne's disease were used in immunoblot analysis. Reactivity to MBP-19 kDa protein, but not MBP
alone, was observed in 9 of 14 infected cattle. Antibodies to the 19-kDa protein were not observed
in 8 of 9 control cows.
Conclusions: Collectively, these results demonstrate that while the 19-kDa protein from M. avium
subsp. paratuberculosis  stimulates a humoral immune response and weak IFN-γ production in
infected cattle, the elicited responses are not strong enough to be used in a sensitive diagnostic
assay.
Background
Paratuberculosis (Johne's disease) is caused by Mycobacte-
rium avium subsp. paratuberculosis (referred to hereafter as
M. avium subsp. paratuberculosis) and induces a chronic
enteritis in ruminants. The disease signs include weight
loss, diarrhea, and decreased milk production. In the
United States alone the economic burden of Johne's dis-
ease is estimated at over $200 million in lost annual reve-
nue to the dairy industry [1]. Prevalence studies in the
United States have estimated that between 20 to 30% of
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dairy herds are infected with M. avium subsp. paratubercu-
losis [2,3]. Neonatal calves are most susceptible to infec-
tion and are likely to become infected after ingestion of
contaminated milk or colostrum [4,5]. During the sub-
clinical stage of infection, the host cell-mediated immune
response is robust and appears to control the infection. As
the disease progresses from the subclinical to the clinical
stage, the cell-mediated response diminishes, and a
humoral immune response predominates [6]. Vaccines
are not completely protective, but have been reported to
reduce fecal shedding and delay the onset of clinical dis-
ease [7-9].
Lipoproteins have long been considered immunomodu-
lators and mycobacteria are especially rich in these post-
translationally modified proteins. There are approxi-
mately 100 open reading frames identified in the M. tuber-
culosis  genome that possess a characteristic amino-
terminal acylation motif [10]. The 19-kDa lipoprotein
from Mycobacterium tuberculosis is immunodominant in
both mice [11-13] and humans [14,15] and has been
shown to stimulate CD4+ T cell proliferation as well as the
release of IL-2, IFN-γ, and IL-12 [16,17]. Acylation near
the N-terminal portion of the 19-kDa protein is believed
to occur at amino acids 19–24 and contributes to its
immunogenicity [12]. Furthermore, glycosylation of the
M. tuberculosis 19-kDa protein inhibits innate immune
responses, such as the release of TNF-α, IL-6, and IL-10
from macrophages, but does not affect antibody binding
[18-20]. The 19-kDa protein was also shown to induce
CD8+ cells to secrete IFN-γ and specifically lyse M. tuber-
culosis-infected monocytes [21] as well as promote neu-
trophil priming and activation [22]. Finally, B cell
epitopes have been described that localize to the linear
sequences of amino acids 11–30, 29–47, 61–80, and
140–159, as well as a conformation-dependent epitope at
the amino and carboxy-terminal ends because of intramo-
lecular disulfide bonding of cysteine residues [21,23].
Experimental infection and staining of macrophages has
shown that the 19-kDa protein is secreted by live M. tuber-
culosis residing within the phagolysosomal compartment
[24]. Homologues of the 19-kDa lipoprotein exist in M.
bovis, M. avium, and M. intracellulare but are absent from
M. phlei, M. smegmatis, M. fortuitum, M. gordonae, and M.
leprae [25].
Despite decades of research, little is known about the M.
avium subsp. paratuberculosis proteins involved in metabo-
lism, cell wall synthesis, macrophage entry and survival,
disease pathogenesis, or host immune evasion. However,
several antigens have recently been identified and their
immunogenicity examined by serodiagnostic and/or lym-
phocyte stimulation assays [26-30]. With the genome
sequence of M. avium subsp.  paratuberculosis  recently
defined [31], all proteins produced by this pathogen are
now identified and can be characterized. Novel opportu-
nities arising from the genome sequence of M. avium
subsp. paratuberculosis enable us to select and characterize
genes of interest. A major goal of this laboratory is to
define a complete catalog of immunodominant antigens
in M. avium subsp. paratuberculosis. With the immunos-
timulatory capabilities of the M. tuberculosis 19-kDa anti-
gen in mind, the objective of this study was to determine
if the 19-kDa protein of M. avium subsp. paratuberculosis
possessed a similar capacity. In this study, the 19-kDa
lipoprotein from M. avium subspecies paratuberculosis was
cloned, expressed, and characterized. In addition, the
purified recombinant protein was used to assess cellular
immune responses in subclinically infected cattle as well
as humoral immune responses in cattle with clinical
Johne's disease.
Results
Sequence analysis of the mycobacterial 19-kDa coding 
region
The 19-kDa coding sequence was identified from the M.
avium  subsp.  paratuberculosis  genome project as
MAP0261c. Comparison of amino acid sequences from
other species of mycobacteria show that this gene product
is conserved. Sequence alignment shows the N-terminal
half is more variable and the region between amino acids
99 and 123 is highly conserved (Figure 1). MAP0261c dis-
plays a 95% amino acid identity in M. avium, 84% in M.
intracellulare  and 76% in M. bovis and  M. tuberculosis.
MAP0261c has a G+C content of 66.2% and encodes for
161 amino acids with a predicted molecular mass of 15.2
kDa. The first 22 amino acids of the M. tuberculosis 19-kDa
protein are hydrophobic and were previously noted to
represent a signal peptide that is post-translationally
cleaved to expose an N-terminal cysteine [32]. Signal
peptidase cleavage analysis of MAP0261c (SignalP3.0;
http://www.cbs.dtu.dk/services/SignalP/) detected a sig-
nal peptide generated from a putative cleavage site
between amino acids 34 and 35, to expose an N-terminal
serine (Figure 1). The SignalP-NN (neural networks)
model assigned the highest cleavage probability values to
amino acid 35 (C score = 0.324; Y score = 0.439) with the
predicted length of the signal peptide being 34 amino
acids. This is slightly longer than most signal sequences
which range from 18 to about 30 amino acid residues in
length [33]. The predicted peptidase cleavage sight for M.
tuberculosis is between amino acids 21 and 22 and there-
fore falls within this range (Figure 1). Despite a predicted
signal peptidase cleavage site, PSORTb analysis software
http://www.psort.org/psortb/ could not predict if the pro-
tein was cytoplasmic or membrane located.BMC Microbiology 2005, 5:3 http://www.biomedcentral.com/1471-2180/5/3
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Cloning and expression of the M. avium subsp. 
paratuberculosis 19-kDa protein
In order to perform immunoassays with purified 19-kDa
protein, MAP0261c was amplified from M. avium subsp.
paratuberculosis genomic DNA and cloned into the pMal-
c2 expression vector and transformed in E. coli. Induced
expression resulted in production of a maltose binding
protein (MBP)-19 kDa fusion protein that was affinity-
purified from E. coli lysates. MBP-19 kDa was analyzed by
SDS-PAGE (Figure 2) to assess yield, purity and size. The
predicted mass of MBP alone is 42 kDa, while the pre-
dicted mass of the MBP-19 kDa fusion protein is 56 kDa.
The purified MBP-19 kDa protein migrated to a position
around 50 kDa in SDS-PAGE (Figure 2A). Approximately
5 mg of purified protein was easily obtained from a 500-
ml broth culture at O.D.600 nm = 0.9. The purified protein
was further characterized by immunoblot analysis using a
monoclonal antibody (mAb) that detects the MBP affinity
tag (Figure 2B). Both the fusion protein and MBP alone
are detected by the mAb. In addition, the fusion protein is
expressed at higher levels under inducing conditions.
Immunoblot analysis of the 19-kDa protein
The M. tuberculosis 19-kDa protein is known to be immu-
nodominant, therefore immunoblot analysis was per-
formed to determine if cattle naturally infected with M.
avium subsp. paratuberculosis produce antibodies against
the 19-kDa protein. Immunoblots were probed with sera
from 9 non-infected and 14 clinically infected cattle. Sera
from 8 of 9 non-infected cattle did not react with either
MBP or MBP-19 kDa, while 1 non-infected cattle weakly
recognized both MBP and MBP-19 kDa protein (data not
shown). By comparison, sera from 9 of 14 infected cattle
reacted specifically with the 19-kDa protein, but not MBP
alone. Antibody reactivity to the 19-kDa protein from 3
clinical cows is shown in Figure 3. Sera from the remain-
ing five infected cattle detected both MBP and MBP-19
kDa proteins. This result made it difficult to distinguish if
Amino acid sequence comparison of the mycobacterial 19 kDa protein Figure 1
Amino acid sequence comparison of the mycobacterial 19 kDa protein. Non-conserved residues are shaded in black 
and gaps in amino acid sequence are indicated by hyphens (-). The predicted signal peptidase cleavage site for M. tuberculosis is 
indicated by a single arrow (↓), while the site for M. avium subsp. paratuberculosis is indicated by a double arrow (‡). The Gen-
Bank accession number and abbreviations are M. avium subsp. paratuberculosis (M. paratb; AAS02578), M. avium subsp. avium 
(M. avium; AAB25888), M. intracellulare (M. intracel; AAB25885), M. bovis (M. bovis; S11234) and M. tuberculosis (M. tuberc; 
NP_218280).BMC Microbiology 2005, 5:3 http://www.biomedcentral.com/1471-2180/5/3
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sera from the animal recognized the MAP0261c gene
product or if it simply recognized the MBP affinity tag.
Collectively, these data suggest that the 19-kDa protein is
detectable and immunogenic in cattle with Johne's
disease.
IFN-γ responses of infected cattle
As an indicator of the cell-mediated responses of infected
cattle to the 19-kDa protein, whole blood containing
PBMCs from 9 control and 21 infected cows was stimu-
lated with M. avium subsp.  paratuberculosis  sonicated
whole cell lysate (WCL), MBP, or MBP-19 kDa and IFN-γ
production was assayed by ELISA. These cattle were
selected from a larger group because they showed no IFN-
γ stimulation in response to MBP alone. IFN-γ production
in response to WCL stimulation allowed for the
segregation of infected cattle into three groups: suspect,
positive, and high positive. After subtracting the IFN-γ
responses of non-stimulated cells, suspect animals had
less than 0.1 absorbance units of IFN-γ production, posi-
tive animals had 0.1 – 0.3 absorbance units of IFN-γ pro-
duction, and high positive animals had more than 0.3
absorbance units of IFN-γ production. IFN-γ responses by
blood mononuclear cells from infected cattle exceeded
responses from control cattle for both the WCL and MBP-
19 kDa (Table 1. Significant differences (P < 0.05) were
found between control and high positive groups for both
WCL and MBP-19 kDa protein stimulation. However,
direct comparisons of the two antigen preps using mono-
nuclear cells from the same animal clearly showed the
WCL was a stronger stimulator of IFN-γ production (Table
1).
Discussion
A majority of the research on individual mycobacterial
proteins has been performed in M. tuberculosis, whereas
little is known about the M. avium subsp. paratuberculosis
proteome. Indeed, all currently available antigen-based
diagnostic tests for Johne's disease use an undefined mix-
ture of proteins, such as purified protein derivative (PPD)
or WCL, which may not be specific for M. avium subsp.
paratuberculosis. Recent completion of the M. avium subsp.
paratuberculosis genome has already advanced efforts to
identify novel antigens [26,34]. Furthermore, the genome
will be a critical resource in proteomic studies directed at
defining the proteins present in mixtures such as johnin
PPD. The present study was performed in order to
characterize the M. avium subsp. paratuberculosis 19-kDa
protein, as well as assess its immunostimulatory capabili-
ties in cattle.
In this study, we show that the 19-kDa protein of M. avium
subsp. paratuberculosis can be readily overexpressed as a
fusion protein in E. coli. This is not true for many other
proteins encoded by M. avium subsp. paratuberculosis [34]
SDS-PAGE and immunoblot analysis of the MBP-19 kDa  fusion protein Figure 2
SDS-PAGE and immunoblot analysis of the MBP-19 
kDa fusion protein. (A) An SDS-PAGE gel showing the 
noninduced and IPTG-induced E. coli protein lysates. Lanes: 
1- protein size markers; 2- noninduced E. coli MBP-19 kDa; 3- 
IPTG induced E. coli MBP-19 kDa; 4- Affinity purified MBP-19 
kDa. (B) Immunoblot probed with a monoclonal antibody to 
MBP. Lane 1- purified MBP; Lane 2- noninduced E. coli MBP-
19 kDa; Lane 3- IPTG induced E. coli MBP-19 kDa.
The recombinant 19-kDa protein is recognized by serum  from infected cattle Figure 3
The recombinant 19-kDa protein is recognized by 
serum from infected cattle. Affinity purified MBP (lane 1) 
and MBP-19 kDa (lane 2) were transferred onto membranes 
in equal amounts and probed with sera from three clinically 
infected cattle: (A) animal 107; (B) animal 116; (C) animal 
167. Reactivity was observed for the 19-kDa protein but not 
the MBP protein. Size standards are indicated in kilodaltons 
in the left margin.BMC Microbiology 2005, 5:3 http://www.biomedcentral.com/1471-2180/5/3
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and suggests the putative lipoprotein is not toxic to E. coli.
Previous studies have suggested the M. tuberculosis 19-kDa
protein undergoes posttranslational modification by the
addition of fatty acids to form a lipoprotein [35].
Although not demonstrated directly by our studies, it is
possible that the 19-kDa was not posttranslationally mod-
ified by the heterologous E. coli host. It is unclear whether
posttranslational modification of this protein would
affect its immunological activity. The recombinant anti-
gen was detected by sera from cattle with Johne's disease;
however, it was not as strong a stimulator of proliferative
T-cell responses as has been reported for its counterpart in
M. tuberculosis [36]. Furthermore, the 19-kDa protein
from M. tuberculosis was shown to induce both cellular
and humoral immune responses from mice and humans
[11,14]. These studies, combined with the present study,
may suggest that acylation is more important in cell-medi-
ated immune responses than in the humoral immune
response.
It is generally accepted that cellular and humoral immune
responses of M. avium subsp. paratuberculosis-infected cat-
tle are biphasic, with IFN-γ responses detected early and
antibody responses detected late in infection. However,
evidence suggests that an unknown M. avium subsp.
paratuberculosis  protein can be detected by antibodies
from cattle just 3 weeks after infection [37]. As a measure
of cellular immune responses, blood mononuclear cells
from infected cattle were stimulated with both the recom-
binant 19-kDa protein and a whole-cell sonicated lysate
of M. avium subsp. paratuberculosis (WCL), and IFN-γ pro-
duction was measured. Results from this study suggest
that while the 19-kDa protein is a stimulator of IFN-γ pro-
duction, it is not as potent when compared to WCL. Addi-
tionally, we found that a majority (9 of 14) of infected
cattle produced antibodies to the 19-kDa protein, as
determined by immunoblot analysis. By comparison, sera
from the majority of control, non-infected cattle (8 of 9)
did not react to the 19-kDa protein. The single non-
infected cow that did show reactivity to the MAP0261c
gene product may be attributed to exposure of environ-
mental mycobacteria such as M. avium subsp.  avium,
which has a similar protein (Figure 1). Sera from four clin-
ical cows reacted to the MBP protein, but this reactivity
was extremely weak. MBP is found in environmental E.
coli and likely accounts for reactivity seen in some cattle.
In order to avoid potential cross-reactivity with MBP, we
attempted to cleave the MBP portion from the MBP-19
kDa fusion protein, but cleavage was not 100% efficient
(data not shown).
The M. tuberculosis 19-kDa protein was reported to con-
tain a 21 amino acid N-terminal signal peptide [22], how-
ever our SignalP analysis for M. avium subsp.
paratuberculosis identified a putative 34 amino acid N-ter-
minal signal sequence. Furthermore, the computer algo-
rithm PSORTb predicts a putative signal sequence, but it
cannot determine if the protein is actually secreted. Anti-
bodies will be produced against the recombinant MBP-19
kDa protein to determine if the protein is secreted by M.
avium subsp. paratuberculosis.
Conclusions
The results from this study show that the recombinant 19-
kDa protein stimulates a weak host immune response in
infected cattle. The 19-kDa protein may be used in con-
junction with other antigens from M. avium subsp. paratu-
berculosis to identify infected cattle but should not be used
as a "stand alone antigen" in new diagnostic assays.
Methods
Bacterial strains and culture conditions
M. avium subsp. paratuberculosis strain 19698-1974 (origi-
nally isolated in 1974 from a clinical cow housed at the
National Animal Disease Center, Ames, IA) was grown in
Middlebrook 7H9 liquid media (pH 6.0) supplemented
Table 1: IFN-γ production by PBMCs in response to WCL and MBP-19 kDa stimulation.
CONTROL 
WCL
CONTROL 
19 KDA
SUSPECT 
WCL
SUSPECT 
19 KDA
POSITIVE 
WCL
POSITIVE 
19 KDA
HIGH POS 
WCL
HIGH POS 
19 KDA
0 0 0.0294 0.0017 0.1058 0.0056 1.2407 0.9212
0.0623 0.0513 0.0980 0 0.1013 0.7737 1.0966 1.125
0.0072 0.0280 0.0412 0.1036 0.1323 0 0.3719 0.0124
0 0 0.0051 0.0286 0.1909 0.0290 0.3348 0.0925
0 0.0429 0.0259 0.0735 0.1623 0.0245 1.1866 0.7230
0.0560 0.0076 0 0 0.1974 0.0299 2.5995 0.0536
0.0561 0.0183 0.0348 0
0.0066 0.0285 0.0203 0.0071
0.0293 0.0236 0.0268 0.0002
Mean 0.0242 0.0222 0.0313 0.0239 0.1483 0.1438 1.1384 0.4880BMC Microbiology 2005, 5:3 http://www.biomedcentral.com/1471-2180/5/3
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with 10% oleic acid albumin dextrose complex (Becton
Dickinson Microbiology, Sparks, MD), 0.05% Tween 80
(Becton Dickinson Microbiology), and 2 mg/ml myco-
bactin J (Allied Monitor Inc., Fayette, MO). M. avium
subsp. paratuberculosis cultures were grown to log phase at
an optical density 540 nm (OD540) of 0.4, at 37°C with-
out shaking. Escherichia coli DH5α cells were routinely
grown in Luria-Bertani (LB) broth or LB agar plates at
37°C supplemented with ampicillin (100 µg/ml) for
selection.
Cattle
The Johne's Disease Research Project at the National Ani-
mal Disease Center has a repository of sera from cattle
that were euthanized with clinical signs of Johne's disease,
which included shedding, weight loss and diarrhea. Fecal
samples from each of these clinical cattle were found to
contain more than 100 CFU per gram of feces as deter-
mined by colony counts on Herrold's egg yolk media
(HEYM) agar slants by standard culture methods [38].
Sera from 14 clinical cattle were selected for immunoblot
analysis. The National Animal Disease Center also main-
tains a small herd of non-infected cattle as well as a herd
of cattle naturally infected with M. avium subsp. paratuber-
culosis. The animals used in IFN-γ experiments were placed
in four groups consisting of 9 non-infected healthy cows,
9 suspect subclinical cows (IFN-γ responses < 0.1), 6 pos-
itive subclinical cows (IFN-γ responses 0.1 – 0.3), and 6
high-positive cows (IFN-γ responses > 0.3). The non-
infected control cows were characterized by repeated neg-
ative fecal cultures performed quarterly over a 3- to 5-year
period. In addition, these animals were negative on all
immunological assays (i.e. ELISA and IFN-γ production)
performed during that period. Subclinical cattle (suspect,
positive, and high-positive) were characterized by shed-
ding less than 10 CFU/g of feces and were intermittently
positive by IFN-γ assays (response > 0.1) performed quar-
terly over a 3- to 5-year period. The institutional Animal
Care and Use Committee approved all animal procedures
described in this study.
Comparison of the mycobacterial 19 kDa coding region
The nucleotide sequences for the 19 kDa coding regions
from M. tuberculosis, M. bovis, M. avium and M. intracellu-
lare were obtained from the NCBI nucleotide sequence
database. The sequences were assembled and compared
using MegAlign software (DNASTAR, Inc., Madison, WI).
Cloning and expression of the M. avium subsp. 
paratuberculosis 19-kDa gene
A maltose binding protein (MBP) fusion of the M. avium
subsp.  paratuberculosis  19-kDa sequence (MBP-19 kDa)
was constructed using the pMAL-c2 vector (New England
Biolabs, Beverly, MA). To amplify the 19-kDa coding
region from M. avium subsp. paratuberculosis, primers were
designed directly from the MAP0261c sequence.
MAP0261c was amplified with Expand High Fidelity PCR
system using the primers 19-kDa-pMal5' (5'-
GCGCCAGCTGACGATCGCGGTCGCGGGCGCGGC-3')
and 19-kDa-pMal3' (5'-GCGCAAGCTTCAGGTCACATC-
GATCTCGAAC-3'). The 19-kDa-pMal5' and 19-kDa-
pMal3' primers contained Pvu II and Hind III restriction
sites (underlined) for cloning, respectively. This primer set
amplified the 19-kDa coding sequence minus the N-ter-
minal 4 amino acids and the C-terminal 3 amino acids.
The pMal-c2 vector was digested with Xmn I and Hind III
and the PCR amplicon was digested with Pvu II and Hind
III. The two products were ligated overnight at 12°C with
T4 DNA ligase (Life Technologies Inc., Rockville, MD),
which resulted in an in-frame fusion between the vector-
encoded malE gene and a majority of the 19-kDa gene.
The resulting recombinant plasmid, designated pMal-19-
kDa, was transformed into E. coli DH5α competent cells.
Recombinant clones were selected by plating on LB-amp-
icillin plates overnight at 37°C. Individual clones were
picked and inserts were confirmed by DNA sequencing.
The resulting fusion protein was overexpressed and puri-
fied by maltose affinity chromatography using amylose
resin (New England Biolabs). A detailed expression and
purification protocol has been published previously [39].
Expression and purification of the MBP-19 kDa fusion
protein was monitored by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) gels either
stained with GelCode Blue (Pierce Biotechnology Inc.,
Rockford, IL) or checked by immunoblot analysis with a
monoclonal antibody against MBP developed at the
National Animal Disease Center. Expression and purifica-
tion of the MBP alone (without 19-kDa) was previously
described [26].
SDS-PAGE and immunoblotting
E. coli lysates expressing MBP-19 kDa were prepared as
previously described [40]. SDS-PAGE was performed
using 12% (wt/vol) polyacrylamide gels. Proteins were
electrophoretically transferred onto nitrocellulose mem-
branes (Schleicher and Schuell, Keene, NH) using the
Trans Blot Cell (Bio-Rad Laboratories, Hercules, CA) in
sodium phosphate buffer (25 mM; pH7.8) at 0.9 amps for
90 minutes. After transfer, the blots were blocked over-
night with PBS plus 2% bovine serum albumin (BSA) and
0.1% Tween 20 (PBS-BSA). For immunoblots, serum
from cattle with Johne's disease was diluted 1:500 in PBS-
BSA. Sera were incubated on the blots at room
temperature for 2 hours. After 3 washes in PBS plus 0.1%
Tween 20, blots were incubated for 1.5 hours in anti-goat
peroxidase-conjugated secondary antibody diluted
1:20,000 in PBS-BSA (Pierce Biotechnology Inc.). After
secondary antibody incubation, the blots were washed 3
times as described above and were developed forBMC Microbiology 2005, 5:3 http://www.biomedcentral.com/1471-2180/5/3
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chemiluminescent detection using SuperSignal detection
reagents (Pierce Biotechnology Inc.).
IFN-γ assays
Blood was collected from the jugular vein of subclinically-
infected cattle into sodium heparin vacutainer blood col-
lection tubes. One ml aliquots of whole blood from each
animal were plated into 4 wells of 24-well culture plates
and cultured alone (non-stimulated) or with 10 µg/ml of
M. avium subsp. paratuberculosis sonicate (WCL), 10 µg/ml
of MBP, or 10 µg/ml of MBP-19 kDa. The WCL was pre-
pared by sonication of bacilli and centrifugation exactly as
described previously [37]. Blood-antigen mixtures were
incubated for 18 hours at 39°C in a 5% CO2 humidified
atmosphere. Plates containing blood-antigen samples
were centrifuged at 500 × g for 15 minutes and the plasma
was harvested from each well. Plasma samples were fro-
zen at -20°C until being analyzed for IFN-γ concentration
by enzyme-linked immunosorbent assay (ELISA) using a
commercial kit (Bovigam, BioCor, Omaha, NE) as recom-
mended by the manufacturer. Samples were analyzed in
duplicate and were determined to be positive for IFN-γ
production if the absorbance of the stimulated sample
(WCL, MBP, MBP-19 kDa) was 0.1 units greater than the
absorbance of the nonstimulated well for that animal.
This classification of IFN-γ positive samples has been pre-
viously reported by our laboratory as well as others
[41,42].
Statistical analysis
ANOVA and unpaired t tests were performed to analyze
the IFN-γ stimulation data. Analyses were performed to
compare average stimulation of control, non-infected cat-
tle to the infected cattle groups (suspect, positive, high
positive). Differences were considered significant when P
< 0.05.
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